2003
DOI: 10.2165/00019053-200321040-00006
|View full text |Cite
|
Sign up to set email alerts
|

Ontario??s Formulary Committee

Abstract: Complex economic analyses had an impact on provincial drug benefit decisions in a limited number of circumstances, principally for expensive innovative products. However, the committee did use some form of economic analysis to guide decisions in almost all cases, and therefore requesting economic analyses, even simple ones, from manufacturers seeking formulary listing is a useful healthcare policy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2003
2003
2016
2016

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 52 publications
(5 citation statements)
references
References 15 publications
0
5
0
Order By: Relevance
“…The role of economic evaluation in the formulary decision process has changed over time. Earlier studies note the need to formally consider PE in decisions in Canada (Martin et al, ; PausJenssen et al, ; Duthie et al, ) and elsewhere (Duthie et al, ). Increasingly the use of PE has been built into the decision process (Barnieh et al, ; Bryan and Williams, ), specifically in the context of cancer drugs (Yong et al, ; Hoch et al, ; Hoch and Sabharwal, ).…”
Section: Challeges Of a Regionalized Review Processmentioning
confidence: 99%
See 2 more Smart Citations
“…The role of economic evaluation in the formulary decision process has changed over time. Earlier studies note the need to formally consider PE in decisions in Canada (Martin et al, ; PausJenssen et al, ; Duthie et al, ) and elsewhere (Duthie et al, ). Increasingly the use of PE has been built into the decision process (Barnieh et al, ; Bryan and Williams, ), specifically in the context of cancer drugs (Yong et al, ; Hoch et al, ; Hoch and Sabharwal, ).…”
Section: Challeges Of a Regionalized Review Processmentioning
confidence: 99%
“…Challenges inherent to economic evaluations of drugs include methodological/technical, understandability, and issues of credibility. Studies can be difficult to understand and interpret by their users, because of insufficient economic training (PausJenssen et al, ; Duthie et al, ; Bryan et al, ; Singer et al, ). Decision makers prefer short summaries and/or research abstracts, and many do not feel equipped to use economic studies (Berry et al, ; Thurston et al, ; Hoffman et al, ; Weizman et al, ).…”
Section: Challeges Of a Regionalized Review Processmentioning
confidence: 99%
See 1 more Smart Citation
“….. other values” [19]. Although CEA has also been promoted as a more precise, apolitical means for resolving difficult priority‐setting problems, studies of actual priority setting show that economic analysis has a limited direct impact on priority setting [20, 21, 22, 23].…”
Section: Priority Setting In Health Carementioning
confidence: 99%
“…Economic analysis is theoretically the ideal decision aid [18]. Ehler (2009) pointed out that economic analysis can provide the framework to consider the requirements of different developers at the same time, and to identify potential conflicts at an early stage [19].…”
Section: Introductionmentioning
confidence: 99%